Inherited susceptibility to bleomycin-induced micronuclei: Correlating polymorphisms in GSTT1, GSTM1 and DNA repair genes with mutagen sensitivity

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 638, Issue 1-2, 2008, Pages 90-97

  Angelini, Sabrina ^a,b   Kumar, Rajiv ^b,c   Carbone, Fabio ^a   Bermejo, Justo Lorenzo ^c   Maffei, Francesca ^a   Cantelli Forti, Giorgio ^a   Hemminki, Kari ^b,c   Hrelia, Patrizia ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Bleomycin; DNA repair genes; Genetic susceptibility; GSTT1 and GSTM1; Micronuclei; Polymorphisms

Indexed keywords

BLEOMYCIN; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; MUTAGENIC AGENT; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN; XRCC3 PROTEIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DNA DAMAGE; DNA POLYMORPHISM; DNA REPAIR; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; INHERITANCE; MALE; MICRONUCLEUS TEST; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BLEOMYCIN; DNA-BINDING PROTEINS; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 37849025276     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2007.09.001     Document Type: Article

References (30)

1. Berwick M., and Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiological review. J. Natl. Cancer Inst. 91 (2000) 874-897
2. Hu J.J., Mohrenweiser H.W., Bell D.A., Leadon S.A., and Miller M.S. Symposium overview: genetic polymorphisms in DNA repair and cancer risk. Toxicol. Appl. Pharmacol. 185 (2002) 64-73
3. Vodicka P., Kumar R., Stetina R., Sanyal S., Soucek P., Haufroid V., Dusinska M., Kuricova M., Zamecnikova M., Musak L., Buchancova J., Norppa H., Hirvonen A., Vodickova L., Naccarati A., Matousu Z., and Hemminki K. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis 25 (2004) 757-763
4. Rzeszowska-Wolny J., Polanska J., Pietrowska M., Palyvoda O., Jaworska J., Butkiewicz D., and Hancock R. Influence of polymorphisms in DNA repair gene XPD, XRCC1, and MGMT on DNA damage induced by gamma radiation and its repair. Radiat. Res. 164 (2005) 132-140
5. Kocabaş N.A., Karahalil B., Karakaya A.E., and Şardaş S. Influence of GSTM1 genotype on comet assay and chromosome aberrations after induction by bleomycin in cultured lymphocytes. Mutat. Res. 469 (2000) 199-205
6. Harsch A., Marzilli L.A., Bunt R.C., Stubbe J., and Vouros P. Accurate and rapid modeling of iron-bleomycin-induced DNA damage using tethered duplex oligonucleotides and electrospray ionization ion trap mass spectrometric analysis. Nucleic Acid Res. 28 (2000) 1978-1985
7. Cloos J., Nieuwenhuis E.J.C., Boomsma D.I., Juik D.J., van der Sterre M.L.T., Arwert F., Snow G.B., and Braakjuis B.J.M. Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral lymphocytes. J. Natl. Cancer Inst. 91 (1999) 1125-1130
8. Tedeschi B., Cicchetti R., Argentin G., Caporossi D., Pittaluga M., Parisi P., and Vernole P. Aphidicolin and bleomycin induced chromosome damage as biomarker of mutagen sensitivity: a twin study. Mutat. Res. 546 (2004) 55-64
9. Wu X., Spitz M.R., Amos C.I., Lin J., Shao L., Gu J., de Andrade M., Benowitz N.L., Shields P.G., and Swan G.E. Mutagen sensitivity has high heritability: evidence from a twin study. Cancer Res. 66 (2006) 5993-5996
10. Fenech M. The in vitro micronucleus technique. Mutat. Res. 455 (2000) 81-95
11. Hagmar L., Stromberg U., Tinnerberg H., and Mikoczy Z. The usefulness of cytogenetic biomarkers as intermediate endpoints in carcinogenesis. Int. J. Hyg. Environ. Health 204 (2001) 43-47
12. Law no. 675, tutela delle persone e di altri soggetti rispetto al trattamento dei dati personali. In Gazzetta Ufficiale 1997, no. 5, S.O., 1996.
13. Sambrook J., Fritsch E.F., and Maniatis R. Molecular Cloning: a Laboratory Manual. 2nd ed. (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
14. Forsti A., Angelini S., Festa F., Sanyal S., Zhang Z., Grzybowska E., Pamula J., Pekala W., Zientek H., Hemminki K., and Kumar R. Single nucleotide polymorphisms in breast cancer. Oncol. Rep. 11 (2004) 917-922
15. Sanyal S., Festa F., Sakano S., Zhang Z., Steineck G., Norming U., Wijkström H., Larsson P., Kumar R., and Hemminki K. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25 (2004) 729-734
16. Fenech M., and Morley A.A. Measurement of micronuclei in lymphocytes. Mutat. Res. 147 (1985) 29-36
17. Maffei F., Fimognari C., Castelli E., Stefanini G.F., Cantelli-Forti G., and Hrelia P. Increased cytogenetic damage detected by FISH analysis on micronuclei in peripheral lymphocytes from alcoholics. Mutagenesis 15 (2000) 517-523
18. Maffei F., Angelini S., Cantelli-Forti G., Lodi V., Violante F.S., Mattioli S., and Hrelia P. Micronuclei frequencies in hospital workers occupationally exposed to low levels of ionizing radiation: influence of smoking status and other factors. Mutagenesis 17 (2002) 405-409
19. Fenech M. The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human population. Mutat. Res. 285 (1993) 35-44
20. Eastmond D.A., and Tucker J.D. Identification of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes and an anti-kinetochore antibody. Environ. Mol. Mutagen. 13 (1989) 34-43
21. D'Agostino R.B., Balanger A., and D'Agostino Jr. R.B. A suggestion for using powerful and informative test of normality. Am. Stat. 44 (1990) 316-321
22. Angelini S., Kumar R., Carbone F., Maffei F., Cantelli-Forti G., Violante F.S., Lodi V., Curti S., Hemminki K., and Hrelia P. Micronuclei in humans induced by exposure to low level of ionizing radiation: influence of polymorphisms in DNA repair genes. Mutat. Res. 570 (2005) 105-117
23. Goode E.L., Ulrich C.M., and Potter J.D. Polymorphisms in DNA repair genes and association with cancer risk. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 1513-1530
24. Kirsch-Volders M., Vanhauwaert A., De Boeck M., and Decordier I. Importance of detecting numerical versus structural chromosome aberrations. Mutat. Res. 504 (2002) 137-148
25. Bonassi S., Ugolini D., Kirsch-Volders M., Stromberg U., Vermeulen R., and Tucker J.D. Human population studies with cytogenetic biomarkers: a review of the literature and future prospectives. Environ. Mol. Mutagen. 45 (2005) 258-270
26. Spitz M.R., Fueger J.J., Beddingfield N.A., Annegers F.J., Hsu T.C., Newell G.R., and Schantz S.P. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive trat cancer. Cancer Res. 49 (1989) 4626-4628
27. Minard C.G., Spitz M.R., Wu X., Hong W.K., and Etzel C.J. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer. Cancer 106 (2006) 2636-2644
28. Wu X., Lin J., Etzel C.J., Dong Q., Gorlova O.Y., Zhang Q., Amos C.I., and Spitz M.R. Interplay between mutagen sensitivity and epidemiological factors in modulating lung cancer risk. Int. J. Cancer 120 (2007) 2687-2695
29. Bonassi S., Neri M., Lando C., Ceppi M., Lin Y.P., Chang W.P., Holland N., Kirsch-Volders M., Zeigher E., Fenech M., and HUMAN collaborative group. Effects of smoking habit on the frequency of micronuclei in human lymphocytes: results from the Human MicroNucleus project. Mutat. Res. 543 (2003) 155-166
30. Norppa H. Cytogenetic biomarkers and genetic polymorphisms. Toxicol. Lett. 149 (2004) 309-334